Skip to main content
Clinical Trials/IRCT138905102709N8
IRCT138905102709N8Completed未知

Effects of intake of Royal Jelly on serum glucose, Insulin, Hb A1c, Apo- AI, Apo- B levels, insulin resistance & blood pressure in type 2 diabetic patients refferred to Endocrine and Metabolism Institue of Iran University of Medical Sciences

Iran University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 65 years (—)
Sex
All

Inclusion Criteria

  • confirmed diabetes type 2 based on physicians diagnosis, being volunteer or willingness to attend, no history of cardiovascular, liver or kidney diseases, not receiving insulin prior to 3 months before the trial, age between 20-65 years old, HbA1c 6-8%, no allergy to honey or its products, BMI between 20-30, duration of type 2 diabetes mellitus for 5 -10 years, no history of smoking and alcohol drinking
  • Exclusion criteria: cholesterol >=240mg/dl, TG>=400mg/dl, incomplete consumption of royal jelly, creation of allergy during the study period, using of any kind of food supplements, pregnancy, lactation, using of oral contraceptive pills, changing medication dosage

Exclusion Criteria

  • Not provided

Investigators

Similar Trials